This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "CMHAFF call, Tuesday June 6"

From HL7Wiki
Jump to navigation Jump to search
(Created page with "Agenda: *Re-orientation to project timeline and goals for next ballot **STU vs Informative -- revisit last week's decision. Gora strongly feels it should be STU to have more ...")
 
Line 11: Line 11:
 
**3.2, (1.2) Product Risk Assessment and Mitigation
 
**3.2, (1.2) Product Risk Assessment and Mitigation
 
*Request for help reviewing European materials
 
*Request for help reviewing European materials
**French guidance
+
**[http://wiki.hl7.org/index.php?title=File:French_good_practice_guidelines_on_mHealth_apps.pdf French guidance]
 
**Draft material from Netherlands
 
**Draft material from Netherlands
 
**Finnish PHR presentation at Madrid (posted on HL7 webpage): are any draft certification criteria available?
 
**Finnish PHR presentation at Madrid (posted on HL7 webpage): are any draft certification criteria available?

Revision as of 20:03, 3 June 2017

Agenda:

  • Re-orientation to project timeline and goals for next ballot
    • STU vs Informative -- revisit last week's decision. Gora strongly feels it should be STU to have more impact
    • Timeline -- Still aim for September ballot, but assess impact on content if changing to STU
  • Review highlighted changes in cMHAFF draft, uploaded HERE
    • 2.3 Lifecycle -- revised based on suggestions from 5/22: publishing on app store, meeting the app store requirements; app enhancements and maintenance after initial release; frequency of updates; keeping current with OS, etc.
    • 2.3.2 Use Case B -- say "regulated" vs "unregulated" and the criteria for what's regulated varies by realm (e.g.,FDA.) European example is in materials Matt sent me. Clarify if examples are realm-specific.
    • 2.3.4 Risk Factors
    • 2.4 Environmental Scan
    • 3.2, (1.2) Product Risk Assessment and Mitigation
  • Request for help reviewing European materials
    • French guidance
    • Draft material from Netherlands
    • Finnish PHR presentation at Madrid (posted on HL7 webpage): are any draft certification criteria available?